The purpose of this study is to identify whether the combination of coconut Nourish and Queen Garnet plum are able to attenuate ageing-related complications, including muscle mass loss and inflammation. The study endpoints will measure muscle mass as the primary endpoint with blood lipids, glucose, blood pressure, and inflammatory markers serving as some of the secondary endpoints. As the two products are rich in dietary fibre and anthocyanins, respectively, the study outcome will help to understand role of these dietary components in improving complications that are seen quite frequently in elderly population.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Enrollment
7
Plain flour, Coconut Nourish, Queen Garnet Plum, Unsalted Butter, Artificial Sweetener
Plain flour, Coconut Powder, Unsalted Butter, Artificial Sweetener, Food Colour
University of Southern Queensland
Toowoomba, Queensland, Australia
Richardson Centre for Functional Foods and Nutraceuticals, University of Manitoba
Winnipeg, Manitoba, Canada
Lean mass
Measured using dual-energy x-ray absorptiometry (DXA)
Time frame: 8 weeks
Body weight
Time frame: 8 weeks
Body mass index
Weight and height will be combined to report BMI in kg/m\^2
Time frame: 8 weeks
Waist circumference
Time frame: 8 weeks
Arm circumference
Time frame: 8 weeks
Wrist circumference
Time frame: 8 weeks
Calf circumference
Time frame: 8 weeks
Triceps skinfold
Time frame: 8 weeks
Five times chair standing test
Time frame: 8 weeks
Handgrip dynamometer
Time frame: 8 weeks
Blood pressure
Systolic and diastolic pressure will be assessed
Time frame: 8 weeks
Heart rate
Time frame: 8 weeks
Bone mineral density
Measured using DXA
Time frame: 8 weeks
Bone mineral content
Measured using DXA
Time frame: 8 weeks
Fat mass
Measured using DXA
Time frame: 8 weeks
Blood total cholesterol
Time frame: 8 weeks
Blood low-density lipoprotein cholesterol
Time frame: 8 weeks
Blood high-density lipoprotein cholesterol
Time frame: 8 weeks
Blood triglycerides
Time frame: 8 weeks
Blood glucose
Time frame: 8 weeks
Blood C-reactive protein
Time frame: 8 weeks
Blood interleukin 1 beta
Time frame: 8 weeks
Blood tumor necrosis factor alpha
Time frame: 8 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.